medigraphic.com
Colegio de Medicina Interna de México.

2010, Number 5

<< Back Next >>

Med Int Mex 2010; 26 (5)

herapeutic pirryc victory?

Poletti ED, Muñoz-Sandoval R

Language: Spanish
References: 27
Page: 492-497
PDF size: 356.69 Kb.


ABSTRACT

Clinical practice implies a constant exercise to self-criticize our own limitations, trying to avoid the ambiguity of information. Therapeuticpyrrhic victory refers to the cases when helping the patients imply limitless efforts and the final result is modest. A frequent medical scenario that evokes this reflection is vitiligo. Even if showing improvement in their mental state, some vitiligo patients display slight benefits after numerous and varied treatments have been applied.


REFERENCES

  2. Larousse. Diccionario enciclopédico usual. 4ª ed. México: Ediciones Larousse, 2008;p:565.

  3. Diccionario de la Lengua Española. Real Academia Española. 20ª ed. México: Espasa-Calpe, 1995;p:1770.

  4. El pequeño Larousse Ilustrado 2010. La pequeña enciclopedia. 1ª ed. México: Larousse, 2010;p:84-87.

  5. López de la Peña X. Los derechos del paciente. 1ª ed. México: Trillas, 2000;p:37-46.

  6. Lasagn L. Hippocratic Oath-Modern Version”. WGBH Educational Foundation for PBS and NOVA Online, 1964. http://www. pbs.org/wgbh/nova/doctors/oah _modern.html. Consultado el 9 de febrero, 2010

  7. Garcia-García C. Lesiones de la pigmentación cutánea. Medicine 2010;10 (48):3195-3203.

  8. Whitton ME, Pinart M, Batchelor J, Lushey C, Leonardi-Bee J, et al. The Cochrane Collaboration. The Cochrane Library. New York: JohnWiley & Sons, 2010;1: 2-136.

  9. Seung-Kyung Hann, Nordlund JJ, Lerner AB. Vitiligo. New York: Blackwell Science, 2010;p:2-6, 18-20, 35-48, 70-75 y 193-201.

  10. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998;38:647-666.

  11. Mazereeuw-Hautier J, Bezio S, Mahe E, Bodemer C, et al. Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: A prospective observational study. J Am Acad Dermatol 2010;62:945-949.

  12. Rezaei N, Gavalas NG, Weetman AP, Kemp EH. Autoimmunity as an aetiological factor in vitíligo. J Eur Acad Dermatol Venereol 2007;21:865-876.

  13. Whitton ME, Ashcroft DM, Gonzalez U. Therapeutic interventions for vitiligo. J Am Acad Dermatol 2008;59:713-717.

  14. Taïeb A, Picardo M, VETF Members. The definition and assessment of vitíligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007;20:27-35.

  15. Singh G, Ansari Z, Dwivedi R. Vitiligo in ancient Indian medicine. Arch Dermatol 1974;109:913.

  16. Gupta AK, Anderson TF, Arbor A. Psoralen photochemotherapy. J Am Acad Dermatol 1987;17:703-734.

  17. Drake LA, Dinehart SM, Farmer ER, Goltz RW, et al. Guidelines of care for vitiligo. J Am Acad Dermatol 1996;35:620-626.

  18. Parrish JA, Fitzpatrick TB, Shea C, Pathak MA. Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system. Arch Dermatol 1976;112:1531-1534.

  19. Al-Aboosi MM, Zuhair AA. Oral photochemotherapy in vitiligo: follow-up, patient compliance. Int J Dermatol 1995;34:206-208.

  20. Wildfang IL, Jacobsen FK, Thestrup-Pedersen K. PUVA treatment of vitiligo: a retrospective study of 59 patients. Acta Derm Venereol 1992;72:305-306.

  21. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A. Arch Dermatol 1997;133:1525-1527.

  22. Stern RS, Thibodeau LA, Kleinerman RA. Risk of cutaneous carcinoma in patients treated with oral methoxalen photochemotherapy for psoriasis. N Engl J Med 2008;300:809-813.

  23. Shaffrali FCG, Gawkrodger DJ. Management of vitiligo. Clin Exp Dermatol 2000;25:575-579.

  24. Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, et al. Guideline for the diagnosis and management. of vitíligo. Br J Dermatol 2008;159:1051-1076.

  25. Salzer B, Schallreuter K. Investigation of the personality structure in patients with vitiligo and a possible association with catecholamine metabolism. Dermatology 1995;190:109-115.

  26. Kent G, Al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996;21:330.

  27. Silverberg NB, Lin P, Travis L, Farley-Li J, et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol 2004;51:760-766.




2020     |     www.medigraphic.com